Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours
Teresa Gelardi(University of Naples Federico II), Claudia De Lorenzo(Federico II University Hospital)
Cited by 39
Related Papers
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs
|British Journal of Cancer|2008|27
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
|Oncotarget|2016|25
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
|Scientific Reports|2021|21
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy
|International Journal of Molecular Sciences|2022|10